Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      SMS Pharmaceuticals gets EIR from USFDA for Kandivalasa facility

      SMS Pharmaceuticals gets EIR from USFDA for Kandivalasa facility

      Medical Dialogues Bureau13 March 2020 2:23 PM IST
      India: SMS Pharmaceuticals has announced the successful closure of inspection with the receipt of Establishment Inspection Report (EIR) from the...
      Lupin Receives International Sustainability Rating System (ISRS) Certification

      Lupin Receives International Sustainability Rating System (ISRS) Certification

      Medical Dialogues Bureau13 March 2020 12:20 PM IST
      Mumbai: Pharma major Lupin Limited has announced that the Company has received certification for International Sustainability Rating System (ISRS),...
      Serum Institute of India collaborates with Novavax  to Develop, Commercialize Malaria Vaccine Candidate

      Serum Institute of India collaborates with Novavax to Develop, Commercialize Malaria Vaccine Candidate

      Medical Dialogues Bureau13 March 2020 11:30 AM IST
      Gaithersburg: Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Serum...
      Tiziana Life Sciences plc to expedite development of TZLS-501 for  COVID-19

      Tiziana Life Sciences plc to expedite development of TZLS-501 for COVID-19

      Medical Dialogues Bureau13 March 2020 11:15 AM IST
      Tiziana's anti-IL-6R mAb binds to both the membrane-bound and soluble forms of IL-6R and rapidly depletes circulating levels of IL-6 in the blood.
      Thermo Fisher Scientific collaborates with Janssen to Develop Companion Diagnostic for Cancer

      Thermo Fisher Scientific collaborates with Janssen to Develop Companion Diagnostic for Cancer

      Medical Dialogues Bureau13 March 2020 9:30 AM IST
      Oncomine Dx Target Test is a next-generation sequencing (NGS) assay that contains 46 cancer-related biomarkers and a workflow that features a fast...
      AbCellera, Eli Lilly join hands for Antibody Therapies for COVID-19

      AbCellera, Eli Lilly join hands for Antibody Therapies for COVID-19

      Medical Dialogues Bureau13 March 2020 9:00 AM IST
      Vancouver and Indianapolis: AbCellera and Eli Lilly and Company have recently announced that they have entered into an agreement to co-develop...
      ISO Biocompatibility Quality Standards to compile with Trivitron Kiran Radiation Protection Products

      ISO Biocompatibility Quality Standards to compile with Trivitron Kiran Radiation Protection Products

      Medical Dialogues Bureau12 March 2020 3:58 PM IST
      New Delhi: Trivitron Healthcare's Imaging Division, Kiran Medical Systems has announced that its all components that can come in contact with the...
      US Patent grants Cellectis to cover CRISPR-Edited Allogeneic CAR T-Cells

      US Patent grants Cellectis to cover CRISPR-Edited Allogeneic CAR T-Cells

      Medical Dialogues Bureau12 March 2020 3:57 PM IST
      New York: Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells...
      Qiagen boosting production of chemical needed to test for coronavirus

      Qiagen boosting production of chemical needed to test for coronavirus

      Medical Dialogues Bureau12 March 2020 1:29 PM IST
      Germany: German molecular testing company Qiagen has said on Wednesday it was ramping up production of a chemical used in some coronavirus tests,...
      Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer

      Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer

      Medical Dialogues Bureau12 March 2020 12:12 PM IST
      CINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus...
      Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi

      Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi

      Medical Dialogues Bureau12 March 2020 11:29 AM IST
      Insulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
      Sami Labs appoints Neeraja Shetty as CEO

      Sami Labs appoints Neeraja Shetty as CEO

      Medical Dialogues Bureau12 March 2020 9:00 AM IST
      Bangalore: Sami-Sabinsa Group, has announced the appointment of Ms Neeraja Shetty as the Chief Executive Officer of Sami Labs (a part of Sami-Sabinsa...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok